Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02010554 · ClinicalTrials.gov registry record · NA

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

A NA study, sponsored by University of Missouri, Kansas City.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02010554: Completed NA study, sponsored by University of Missouri, Kansas City.

NCT02010554 is a NA study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02010554, a NA study, has completed, sponsored by University of Missouri, Kansas City.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Between 15-20% of MS patients decide not to initiate disease modifying therapies after being diagnosed with MS. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in initiating disease modifying medications than patients given brief education and treatment as usual.

Primary Outcome

Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a "yes"/"no" question.

Interventions

  • BEHAVIORAL Motivational Interviewing-Cognitive Behavioral Therapy
  • BEHAVIORAL Brief Education

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-12
Est. Completion 2015-09
Phase NA

What the finished NCT02010554 record still lists

NCT02010554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing-Cognitive Behavioral Therapy is the first listed.

NCT02010554 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02010554 about?

NCT02010554 is a clinical study titled "Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS". Between 15-20% of MS patients decide not to initiate disease modifying therapies after being diagnosed with MS. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone...

What is the current status of trial NCT02010554?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-12. Estimated completion is 2015-09.

What interventions are being tested in trial NCT02010554?

The interventions under investigation include: Motivational Interviewing-Cognitive Behavioral Therapy (BEHAVIORAL), Brief Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02010554?

This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02010554's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02010554, the US trial registry maintained by the National Library of Medicine. NCT02010554 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.